Vertigo medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
=== Acute Pharmacotherapies === | === Acute Pharmacotherapies === | ||
==== Peripheral disorders==== | |||
* Specific management | |||
# BPPV | |||
# Epley maneuver --> in a randomized controlled trial, symptoms resolved in 50% vs. 19% sham therapy by mean 10 days | |||
# Meclizine (12.5-50 mg every 6 hours as often as necessary) or promethazine (25 mg every 6 hours as often as necessary) for severe symptoms | |||
# Meniere’s disease: low-salt diet and diuretics to reduce endolymph production | |||
*General management | |||
=====Pharmacologic therapy===== | |||
*For acute episodes: | |||
#Avoid long-term therapy if symptoms last > few days (will reduce CNS adaptation) | |||
#Anticholinergics | |||
#Scopolamine: Side effect urinary retention, dry mouth | |||
#Antihistamines | |||
#Meclizine, dimenhydrinate, diphenhydramine (anti-Ach effects) | |||
#Meclizine is drug of choice in pregnancy. Side effect: sedation | |||
#Phenothiazines | |||
#prochlorperazine, promethazine (anti-Ach effects): More sedating, but also have antiemetic effects. Risk: extrapyramidal side effect (second-line) | |||
#Benzodiazepines | |||
#Diazepam, lorazepam, clonazepam (GABA-ergic effects): For patients with contraindications to anti-Ach prescription (benign prostatic hypertrophy) | |||
==References== | ==References== | ||
Revision as of 15:31, 4 March 2013
|
Vertigo Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Vertigo medical therapy On the Web |
|
American Roentgen Ray Society Images of Vertigo medical therapy |
|
Risk calculators and risk factors for Vertigo medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Central disorders
- Treat underlying disease
- Vertebrobasilar ischemia
- Vertigo usually resolves on its own
- Risk factor modification to decrease recurrence
- Revascularization or anticoagulation
- Migraine: adequate treatment of headache improves vertigo in 90%
- Multiple sclerosis (MS): Therapy for MS alleviates vertiginous symptoms as well
- Drugs: discontinue offending agents
Peripheral disorders
- General management
- Physical therapy
- Beneficial in patients with permanent peripheral vestibular dysfunction
- Unknown benefit in patients with central disorders
- Vestibular rehabilitation
- Activity enables CNS adaptation to loss of vestibular input
- Visual compensation during head motion
- Balance shown to improve in randomized controlled trials of vestibular exercises
- Unclear if long-term benefits or if decreased fall risk
- Avoidance of inactivity
- Avoid deconditioning and loss of postural reflexes
Acute Pharmacotherapies
Peripheral disorders
- Specific management
- BPPV
- Epley maneuver --> in a randomized controlled trial, symptoms resolved in 50% vs. 19% sham therapy by mean 10 days
- Meclizine (12.5-50 mg every 6 hours as often as necessary) or promethazine (25 mg every 6 hours as often as necessary) for severe symptoms
- Meniere’s disease: low-salt diet and diuretics to reduce endolymph production
- General management
Pharmacologic therapy
- For acute episodes:
- Avoid long-term therapy if symptoms last > few days (will reduce CNS adaptation)
- Anticholinergics
- Scopolamine: Side effect urinary retention, dry mouth
- Antihistamines
- Meclizine, dimenhydrinate, diphenhydramine (anti-Ach effects)
- Meclizine is drug of choice in pregnancy. Side effect: sedation
- Phenothiazines
- prochlorperazine, promethazine (anti-Ach effects): More sedating, but also have antiemetic effects. Risk: extrapyramidal side effect (second-line)
- Benzodiazepines
- Diazepam, lorazepam, clonazepam (GABA-ergic effects): For patients with contraindications to anti-Ach prescription (benign prostatic hypertrophy)